Skip to main content
Premium Trial:

Request an Annual Quote

CST and AstraZeneca to Identify Phosphorylation Profiles in Pilot

NEW YORK, Jan. 10 (GenomeWeb News) - Cell Signaling Technology will expand a pilot study on phosphorylation profiles with AstraZeneca, the company said today.

 

As reported in Cell-Based Assay News  in June 2004, the pilot study will identify phosphorylation profiles and prospective biomarkers of kinase-targeted lead compounds.

 

CST's PhosphoScan proteomics technology identifies Phospho-Signatures in cells and disease tissues to enable the development of biomarker assays for target validation.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.